We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

37 hedge funds and large institutions have $37.9M invested in Abeona Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

78% more capital invested

Capital invested by funds: $21.2M → $37.9M (+$16.6M)

12% more funds holding

Funds holding: 33 → 37 (+4)

7.15% more ownership

Funds ownership: 42.5% → 49.64% (+7.1%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
37
Holders Change
+4
Holders Change %
+12.12%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
8
Closed
5
Calls
$548K
Puts
–
Net Calls
+$548K
Net Calls Change
+$548K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.8M
2
JGC
J. Goldman & Co
New York
+$1.74M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$739K
5
Citigroup
Citigroup
New York
+$700K

Top Sellers

Rank Fund Capital Flow
1
ECM
ExodusPoint Capital Management
New York
-$341K
2
NCM
Nantahala Capital Management
Connecticut
-$93.7K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$87.1K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$67.2K
5
Creative Planning
Creative Planning
Kansas
-$62.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$10.5K – – –
UBS Group
27
UBS Group
Switzerland
$4.45K +$3.87K +1,105 New
HFM
28
Hartford Financial Management
Connecticut
$2.9K -$94 -27 -4%
Simplex Trading
29
Simplex Trading
Illinois
$2K +$2.48K +710 New
PA
30
Parallel Advisors
California
$1.61K – – –
Wells Fargo
31
Wells Fargo
California
$516 +$52 +15 +13%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$233 +$203 +58 New
TC
33
Truvestments Capital
Florida
$206 – – –
Fidelity Investments
34
Fidelity Investments
Massachusetts
$64 +$56 +16 New
JP Morgan Chase
35
JP Morgan Chase
New York
$56 -$2.46K -704 -98%
CT
36
Cambridge Trust
Massachusetts
$52 – – –
2L
37
25 LLC
Missouri
$20 – – –
ECM
38
ExodusPoint Capital Management
New York
– -$341K -120,853 Closed
Creative Planning
39
Creative Planning
Kansas
– -$62.1K -22,011 Closed
Charles Schwab
40
Charles Schwab
California
– -$50.8K -18,000 Closed
PF
41
Phoenix Financial
Israel
– -$33.3K -11,874 Closed
TRCT
42
Tower Research Capital (TRC)
New York
– -$2K -640 Closed
1
2

ABEO Hedge Fund Activity: Q2 2023 in Review

37 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2023, worth a combined $37.9M — up 78% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ABEO positions and 5 closed out — a net gain of 4 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.8M. The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $341K sold.

  • 37 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2023, up from 33 in Q1 2023.
  • Funds reported $37.9M of Abeona Therapeutics stock for Q2 2023, up 78% quarter-over-quarter.
  • 9 funds opened new Abeona Therapeutics positions in Q2 2023 and 5 closed out, a net change of +4 holders.
  • The largest Abeona Therapeutics buyer in Q2 2023 was Millennium Management, an estimated $1.8M added.
  • The largest Abeona Therapeutics seller in Q2 2023 was ExodusPoint Capital Management, an estimated $341K sold.

Based on aggregated 13F filings for Q2 2023.